Collaboration is an essential part of DNDi’s model: we cannot carry out our work without the engagement of public and private partners.

Acting as a ‘conductor of a virtual orchestra,’ we leverage and give value to our partners’ specific assets, capacities, and expertise. At every phase of the R&D process – from drug discovery and pre-clinical research to clinical trials and large-scale implementation studies – DNDi manages the process, creating multiple alliances, strengthening cross-sector networks, and working in close partnership with a broad range of different actors.

Today, DNDi has forged a diverse range of alliances and research collaborations with over 200 partners in more than 40 countries.